-
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Study
EGAS50000000136
-
Genomic profiling of paediatric glioma cell lines
Study
EGAS00001003006
-
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Study
EGAS50000000168
-
Whole exome sequencing of peripheral T-cell lymphoma (PTCL)
Study
EGAS00001000557
-
Profiling of Peritoneal Metastases from Gastric Adenocarcinoma Identified Molecular Subtypes
Study
EGAS00001003180
-
Karyotype Evolution in Response to Chemoradiotherapy and Upon Recurrence of Esophageal Adenocarcinomas
Study
EGAS00001007711
-
Comprehensive spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Study
EGAS50000000220
-
Single-cell atlas of penile cancer reveals TP53 mutations as driver for an aggressive phenotype, irrespective of HPV status, and provides clues for treatment personalization
Study
EGAS50000000217
-
Clonal Evolution and Blastic Plasmacytoid Dendritic Cell Neoplasm - Two Cases
Study
EGAS50000000214
-
Whole genome and RNAseq analysis of pediatric osteosarcoma
Study
EGAS00001003201